Join the UsAgainstAlzheimer's Membership Program

Become a Member of UsAgainstAlzheimer's today and join a movement of people who don’t just talk about the Alzheimer’s crisis, but become part of the solution.

FDA Advisory Committee Unanimously Endorses Donanemab for Full Approval

An advisory committee convened by the Food and Drug Administration (FDA) to evaluate Donanemab unanimously endorsed the drug for full FDA approval on Monday. Donanemab is a disease modifying drug that slows the progression of Alzheimer’s disease by targeting amyloid plaque in the brain. George Vradenburg, chair and co-founder of UsAgainstAlzheimer’s, issued the following statement in response to this positive development.

More Evidence that “What’s Good for the Heart is Even Better for The Brain” in early-stage Alzheimer’s patients

New study demonstrates how diet, exercise, and other interventions improved brain cognition and function after just 20 weeks

2024 Brain Health Academy

UsAgainstAlzheimer’s is bringing back its Brain Health Academy in May 2024. First launched in 2022, the Academy offers a free, comprehensive virtual program designed to equip healthcare providers and wellness professionals with the necessary tools and resources to reduce the risks associated with Alzheimer’s and related dementias. In collaboration with the American Society on Aging, participants will receive free continuing education credits to enhance their professional development and growth. Learn more about how you can access this resource today.

Listen to the BrainStorm Podcast

Featuring conversations with healthcare providers, researchers, authors, experts, caregivers, and more, BrainStorm is breaking through the silence of Alzheimer's disease. Tune in on the first and third Tuesdays of every month for a new episode, with our host, Meryl Comer.

Vivian Vasallo Appointed Vice President for Early Detection

UsAgainstAlzheimer’s is pleased to announce the appointment of Vivian Vasallo as Vice President of Early Detection. In this role, Vasallo will lead and manage the efforts at UsAgainstAlzheimer’s to identify Alzheimer’s disease in its earliest stages.

Become a Member

FDA Advisory Committee Endorses Donanemab

"What’s Good for the Heart is Even Better for The Brain”

2024 Brain Health Academy

Listen to the BrainStorm Podcast

New Vice President for Early Detection

UsAgainstAlzheimer’s is engaged in a relentless pursuit to end Alzheimer’s, the sixth leading killer in America. Our work centers on prevention, early detection and diagnosis, and access to treatments – all regardless of gender, race, or ethnicity. To achieve our mission, we give voice to patients and caregivers while partnering with government, scientists, the private sector, and allied organizations -- the people who put the “Us” in UsAgainstAlzheimer’s.

Prevention

Alzheimer’s is not a normal part of aging. There are things we can all do to reduce our risk, like eating a healthy diet, exercising, and getting good sleep. People need to know what’s good for the body is good for the brain. Learn more about our prevention work and how you can take charge of your brain health.

CLICK HERE FOR MORE INFO

Early Detection & Diagnosis

Early detection and diagnosis give people a better chance of managing the disease. On top of that, current treatments are most effective with patients in the early stages of dementia.

Find out how we are raising awareness of the importance of early detection and how BrainGuide is helping people concerned about their brain health start a conversation with their doctor.

CLICK HERE FOR MORE INFO

Access to Treatments

We are working on multiple fronts to get safe and effective treatments into the hands of people who need them most. That includes working to ensure Alzheimer’s patients are treated fairly as the federal government considers drug approval and Medicare coverage for treatments.

See how else UsAgainstAlzheimer’s is fighting for access to treatments.

CLICK HERE FOR MORE INFO

 

Center for Brain Health Equity

Most Alzheimer’s patients are women, Latinos, and Black people. As a patient-centered organization, all our work is done with equity in mind, so we are addressing needs of the people who are most heavily impacted by the disease. Learn more about how UsAgainstAlzheimer’s Center for Brain Health Equity is working toward a healthcare system that works for everyone.

Recent News and Blog Posts

  • 30 Years On, Are We Winning the Fight Against Alzheimer’s?

    Lecanemab, Donanemab, Drug-Free Strategies Emerge as New Weapons Against Dementia

    By Suzanne Leigh...

    Read more
  • December 23, 2022

    Congress Delivers Major Wins for Alzheimer’s Patients

     Alzheimer’s patients, caregivers, and advocates secured major wins in the end-of-year budget...

    Read more
  • A-LIST Pulse of the Community Vol 14, December 2022

    The mission of the A-LIST is to use survey results to make...

    Read more
  • December 01, 2022

    Gantenerumab Trial Results Reinforce Need for Continued Research and Treatment-Specific Regulation

    Yesterday, at the Clinical Trials on Alzheimer’s Disease (CTAD) conference, researchers ...

    Read more
  • November 30, 2022

    Lecanemab Trial Data Gives Hope to Alzheimer’s Community

    Washington, DC (November 29, 2022) – Promising new data released today...

    Read more
  • November 21, 2022

    Faith in Action Campaign Launches to Promote Brain Health Among Black Americans

    Faith in Action Campaign Launches to Promote Brain Health Among Black American

    Read more

Reports

  • Resources

    2022 Annual Report

  • Resources
    alist 2023

    A-LIST Pulse of the Community – July 2023

  • Resources

    A-LIST Pulse of the Community – November 2022